NEFL p.Gln537Arg
c.1610A>G · rs377121179 · VCV220209
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0969 | likely benign |
|---|---|---|
| SaProt | LLR -6.75 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.6 | GERP 1.9, phastCons 1 |
| Regional constraint | o/e 0.93 | unconstrained · MANE · 3,702 bp · p 0.058 · regional, not allelic |
| Overall | ||
| CADD | 21.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; SaProt is an independent agreement signal.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.154% | 651 |
| European (non-Finnish)grpmax | 0.0994% | 1,007 |
| Admixed American | 0.0816% | 1,225 |
| African / African-American | 0.0147% | 6,823 |
| Finnishnot grpmax-eligible | 0.00781% | 12,801 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NEFL
- Protein
- p.Gln537Arg
- Coding
- c.1610A>G
- MANE Select
- NM_006158
- dbSNP
- rs377121179
- Type
- single nucleotide variant
- Location
- chr8:24952832 (GRCh38)
- Gene constraint
- LOEUF 0.986 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
- Structure
- AlphaFold pLDDT 73.66
- Residue 537
- the 'tail' region; the 'tail, subdomain b (acidic)' region; the 'disordered' region
Disease context
Charcot-Marie-Tooth disease type 1F — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Charcot-Marie-Tooth disease type 2ECharcot-Marie-Tooth disease, dominant intermediate G
For Charcot-Marie-Tooth disease type 1F (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Childhood, Infancy
Similar variants
- NEFL p.Gln537= Likely benign ★★ same residue
- NEFL p.Arg399Ter Pathogenic/Likely pathogenic ★★ same condition
- NEFL p.Arg421Ter Pathogenic ★★ same condition
- NEFL p.Asn98His Likely pathogenic ★★ same condition
- NEFL p.Asn98Ser Pathogenic/Likely pathogenic ★★ same condition
- NEFL p.Glu186Ter Pathogenic/Likely pathogenic ★★ same condition
- NEFL p.Glu396Lys Pathogenic ★★ same condition
- NEFL p.Glu90Lys Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nefl-p-gln537arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown